Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.09

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.09), versus $0.02 reported last year. Revenue for the quarter came in at $8.6 million, versus $9.6 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• More trouble for SpaceX? Analyst flags robotics and space as key bubble risk areas
• Paychex beats fourth quarter EPS estimates, stock slides